urothelial carcinoma

You have access
Imbalance Between CD44 and STAT3 Enhances Spheroid Viability and Impairs Pembrolizumab Response in Urothelial Cancer
KEITA GOTO, KIYOHIRO ANDO, NORIKO MOTOI, TOSHIHIKO IIZUKA, HIROTAKA FUCHIZAWA, YUKI NAKAMURA, YUTA SANO, SHOTARO MATSUOKA, HISANORI TAKENOBU, MASAYUKI HARUTA, RITSUKO ONUKI, YOH MATSUOKA, TAKEHIKO KAMIJO and YUKIO KAGEYAMA

Anticancer Research May 2026, 46 (5) 2445-2453; DOI: https://doi.org/10.21873/anticanres.18129
You have access
Severe Esophageal Ulceration With Enfortumab Vedotin Plus Pembrolizumab Therapy in Urothelial Carcinoma: A Case Report
HIROKI BAMBA, SATOSHI YAMAMOTO, KEITA HIGA, KOICHIRO KUROKAWA, SANJI KANAOKA and KAZUYOSHI NAKAMURA

Anticancer Research March 2026, 46 (3) 1747-1753; DOI: https://doi.org/10.21873/anticanres.18069
You have access
Renal Function With Enfortumab Vedotin in Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study in Japan
YUKI KOBARI, JUNPEI IIZUKA, HANAE KONDO, MAKIKO ICHIOKA, SHUN WATANABE, KAZUTAKA NAKAMURA, YUKI NEMOTO, TOSHIHIDE HORIUCHI, SHINSUKE MIZOGUCHI, KAZUHIKO YOSHIDA, HIROAKI SHIMMURA, YASUNOBU HASHIMOTO, TSUNENORI KONDO, HIROSHI KOBAYASHI and TOSHIO TAKAGI

Anticancer Research December 2025, 45 (12) 5645-5654; DOI: https://doi.org/10.21873/anticanres.17898
Open Access
Management of Bladder Cancer During Pregnancy: A Narrative Review
LUCIO DELL’ATTI

Anticancer Research November 2025, 45 (11) 4689-4695; DOI: https://doi.org/10.21873/anticanres.17819
Open Access
Novel UF-5000-based Detection, Integrating Inflammatory Parameters, for Urothelial Carcinoma of the Urinary Bladder
KAZUHIRO OKADA, YOSHIKI NAITO, SAORI IRIE, CHIKA NAKAMOTO, KENJI KUBOYAMA, TOSHIKI TARUMIZU, MISAKI IKEDA, YUKO TAKUMA, RYO MAKINO, AKIHIKO KAWAHARA and HIROYUKI KAWANO

Anticancer Research August 2025, 45 (8) 3531-3541; DOI: https://doi.org/10.21873/anticanres.17714
Open Access
Treatment Outcomes After Progression With Enfortumab Vedotin in Patients With Advanced Urothelial Carcinoma
NOBUKI FURUBAYASHI, MANABU MOCHIDA, ATSUHIRO KIJIMA, YUSHI FUJIMOTO, MOTONOBU NAKAMURA and TAKAHITO NEGISHI

Anticancer Research May 2025, 45 (5) 2185-2193; DOI: https://doi.org/10.21873/anticanres.17592
Open Access
Unusual Presentation of Advanced Urothelial Cancer in a Young Patient
DANIELA GUEVARA, NARA SHIN, ALEXANDRA BOIKO, IVAN VALIEV, AHMED G. ELSAEED, JUAN MIGUEL MOSQUERA, MAJD AL ASSAAD, JYOTHI MANOHAR, MICHAEL SIGOUROS, ALISA ZAICHIKOVA, VICTORIA FOMCHENKOVA, LEYSAN YUNUSOVA, SOFIA SMIRNOVA, OLIVIER ELEMENTO, DAVID NANUS and CORA N. STERNBERG

Anticancer Research February 2025, 45 (2) 613-618; DOI: https://doi.org/10.21873/anticanres.17448
Open Access
Systemic Inflammation Indexes and Risk of Immune-related Adverse Events in Patients With Metastatic Urothelial Carcinoma Treated With Immunotherapy
MICHELE DIONESE, DAVIDE BIMBATTI, FRANCESCO PIERANTONI, ELEONORA LAI, ELISA ERBETTA, NICOLÒ CAVASIN, SALIM JUBRAN, UMBERTO BASSO and MARCO MARUZZO

Anticancer Research October 2024, 44 (10) 4379-4386; DOI: https://doi.org/10.21873/anticanres.17267
Open Access
The Novel Platinum Analog Dicycloplatin Provides Reliable Growth Inhibition of Urothelial Carcinoma Cells In Vitro
DAVID ZEKAN, THOMAS HOGAN, BARBARA JACKSON, GARRETT JACKSON and STANLEY KANDZARI

Anticancer Research August 2024, 44 (8) 3243-3254; DOI: https://doi.org/10.21873/anticanres.17142
Open Access
Enfortumab Vedotin for Elderly Advanced Urothelial Carcinoma Patients or Those With a Poor Performance Status
NOBUKI FURUBAYASHI, AKINORI MINATO, TOSHIHISA TOMODA, HIROYUKI MASAOKA, YOSHIFUMI HORI, KEIJIRO KIYOSHIMA, TAKAHITO NEGISHI, YUSUKE HARAGUCHI, TOSHIKI KOGA, YOOHYUN SONG, KENICHI HARADA, KENTARO KUROIWA, NARIHITO SEKI, NAOHIRO FUJIMOTO, MOTONOBU NAKAMURA and Uro-Oncology Group in Kyushu (UROKYU)

Anticancer Research August 2024, 44 (8) 3409-3417; DOI: https://doi.org/10.21873/anticanres.17161

Main menu

User menu

Search

urothelial carcinoma

Pages